GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (FRA:PSH) » Definitions » Shiller PE Ratio

Sernova (FRA:PSH) Shiller PE Ratio : (As of May. 13, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sernova Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Sernova Shiller PE Ratio Historical Data

The historical data trend for Sernova's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Shiller PE Ratio Chart

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sernova's Shiller PE Ratio

For the Biotechnology subindustry, Sernova's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sernova's Shiller PE Ratio falls into.



Sernova Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sernova's E10 for the quarter that ended in Jan. 2024 is calculated as:

For example, Sernova's adjusted earnings per share data for the three months ended in Jan. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.021/125.4675*125.4675
=-0.021

Current CPI (Jan. 2024) = 125.4675.

Sernova Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201404 -0.007 98.920 -0.009
201407 -0.007 99.315 -0.009
201410 0.000 99.473 0.000
201501 -0.003 98.209 -0.004
201504 -0.007 99.710 -0.009
201507 -0.003 100.579 -0.004
201510 -0.007 100.500 -0.009
201601 -0.003 100.184 -0.004
201604 -0.003 101.370 -0.004
201607 -0.007 101.844 -0.009
201610 -0.003 102.002 -0.004
201701 -0.001 102.318 -0.001
201704 -0.003 103.029 -0.004
201707 -0.003 103.029 -0.004
201710 -0.007 103.424 -0.008
201801 -0.003 104.056 -0.004
201804 -0.006 105.320 -0.007
201807 -0.007 106.110 -0.008
201810 0.000 105.952 0.000
201901 -0.003 105.557 -0.004
201904 -0.003 107.453 -0.004
201907 -0.007 108.243 -0.008
201910 -0.007 107.927 -0.008
202001 -0.007 108.085 -0.008
202004 -0.007 107.216 -0.008
202007 -0.006 108.401 -0.007
202010 0.000 108.638 0.000
202101 -0.006 109.192 -0.007
202104 -0.007 110.851 -0.008
202107 -0.007 112.431 -0.008
202110 0.000 113.695 0.000
202201 -0.014 114.801 -0.015
202204 -0.015 118.357 -0.016
202207 -0.015 120.964 -0.016
202210 -0.022 121.517 -0.023
202301 -0.021 121.596 -0.022
202304 -0.020 123.571 -0.020
202307 -0.021 124.914 -0.021
202310 -0.028 125.310 -0.028
202401 -0.021 125.468 -0.021

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sernova  (FRA:PSH) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Sernova Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Sernova's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova (FRA:PSH) Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (FRA:PSH) Headlines